Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04817254
What this trial is testing

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcomaMalignant Glioma
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Early research (Phase 1)Active Not RecruitingNCT04015700
What this trial is testing

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 9
Testing effectiveness (Phase 2)Ended earlyNCT01822275
What this trial is testing

Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme

Who this might be right for
Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
University of Maryland, Baltimore 24
Early research (Phase 1)Looking for participantsNCT07141732
What this trial is testing

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Who this might be right for
Glioblastoma
Joint Stock Company European Medical Centre 15
Not applicableUnknownNCT02047058
What this trial is testing

Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics

Who this might be right for
GlioblastomaMalignant Glioma
Nanfang Hospital, Southern Medical University 240
Testing effectiveness (Phase 2)Study completedNCT03782415
What this trial is testing

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM+1 more
MediciNova 64
Early research (Phase 1)Ended earlyNCT03250299
What this trial is testing

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaMGMT-Unmethylated Glioblastoma
Basilea Pharmaceutica 26
Very early researchStudy completedNCT01867593
What this trial is testing

MET-PET for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 20
Not applicableWithdrawnNCT00645385
What this trial is testing

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma
Weill Medical College of Cornell University
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Early research (Phase 1)Study completedNCT03224104
What this trial is testing

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

Who this might be right for
Astrocytoma, Grade IIIGlioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 71
Large-scale testing (Phase 3)Active Not RecruitingNCT05685004
What this trial is testing

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme of Brain
TVAX Biomedical 120
Testing effectiveness (Phase 2)Study completedNCT02366728
What this trial is testing

DC Migration Study for Newly-Diagnosed GBM

Who this might be right for
GlioblastomaAstrocytoma, Grade IVGiant Cell Glioblastoma+1 more
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 64
Large-scale testing (Phase 3)Study completedNCT01364064
What this trial is testing

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
King Faisal Specialist Hospital & Research Center 1,153
Not applicableStudy completedNCT01653834
What this trial is testing

Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas

Who this might be right for
Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Testing effectiveness (Phase 2)Study completedNCT00305864
What this trial is testing

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 118
Large-scale testing (Phase 3)Study completedNCT00753246
What this trial is testing

Nimotuzumab in Adults With Glioblastoma Multiforma

Who this might be right for
Adults With Glioblastoma Multiforma
Oncoscience AG 150
Very early researchNot Yet RecruitingNCT07778602
What this trial is testing

Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)IDH Wildtype Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Early research (Phase 1)Study completedNCT00053183
What this trial is testing

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Next Page